Rakuten Medical

Rakuten Medical (formerly Rakuten Aspyrian and previously Aspyrian Therapeutics) is a clinical stage biotechnology company which is focused on the development of targeted therapies in the area of oncology based on its Photoimmunotherapy platform.In September 2022, Rakuten Medical Inc established its subsidiary in India, Rakuten Medical Private Limited (Rakuten Medical India).The company has its headquarters in San Mateo, CA, and offices in San Diego, CA as well as Tokyo, Japan and Sinn-Fleisbach, Germany.In January 2021, Rakuten Medical Japan Co., Ltd. have signed an agency contract for Setuximab Salotarocan Sodium with SPLine Co., Ltd. , a wholly-owned subsidiary of Medipal Holdings Co., Ltd.In July 2021, Rakuten Medical Inc announced the completion of a $166 million Series D financing led by General Catalyst.In August 2018, Aspyrian raised $150 million in a Series C financing, bringing the total fundraising to approximately $238 million in equity. In December 2018, the compa